Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Patent
1987-11-24
1992-09-22
Russel, Jeffrey E.
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
530412, C07K 302, C07K 312
Patent
active
051497875
ABSTRACT:
A method for maintaining intact, non-degraded von Willebrand factor by preventing the action of calcium activated protease(s) responsible for degradation of the factor. The action of the calcium activated protease(s) may be avoided by removing the blood platelet source of the protease(s), by filtering or centrifugal separation, or by inactivating the protease with a chelating agent removing the calcium, by a protease inhibitor, or an alkylating agent.
REFERENCES:
patent: Re29698 (1978-07-01), Fekete
patent: 3920625 (1975-11-01), Andersson
patent: 4022758 (1977-05-01), Andersson et al.
patent: 4203891 (1980-05-01), Rock
patent: 4221780 (1980-09-01), Cort
patent: 4235881 (1980-11-01), Cort
patent: 4278594 (1981-07-01), Amrani et al.
patent: 4302445 (1981-11-01), Pla et al.
patent: 4305871 (1981-12-01), Shanbrom
patent: 4348384 (1982-09-01), Horikoshi et al.
patent: 4359463 (1982-11-01), Rock
patent: 4361509 (1982-11-01), Zimmerman
patent: 4364861 (1982-12-01), Mitra
patent: 4383989 (1983-05-01), Rock
patent: 4386068 (1983-05-01), Mitra et al.
patent: 4391746 (1983-07-01), Mitra et al.
patent: 4395396 (1983-07-01), Eibl et al.
patent: 4397841 (1983-08-01), Johnson et al.
patent: 4404131 (1983-09-01), Schwarz et al.
patent: 4404132 (1983-09-01), Mitra
patent: 4406886 (1983-09-01), Bier et al.
patent: 4471112 (1984-09-01), Johnson et al.
"Specific Factor VIII-Related Antigen Fragmentation: An In Vivo and In Vitro Phenomenon", Blood, vol. 60, p. 930, et seq., Oct., 1982.
Human Platelet Calcium-Activated Protease (CAP): Degradation of Fibrogen and Modification of von Willebrand Factor, Blood, vol. 62, (Supp. 1), p. 260a, Nov. 1983.
"Purification of Human Platelet Calcium-activated Protease", the Journal of Biological Chemistry, vol. 258, No. 11, pp. 7168-7174, Jun. 1983.
"Clevage of Human Platelet Fibrogen and Factor VIII/von Willebrand Factor (FVIII/vWf) by Endogenous Calcium-Activated Protease", received for publication by The Journal of Clinical Investigation, May 24, 1983, not published.
"Factors Influencing the Multimeric Structure of Human Platelet von Willebrand Factor", received for publication by Blood, Oct. 7, 1983, Revised and published Aug. 1, 1984 under the title Cleavage of Human von Willebrand Factor By Platelet Calcium-Activated Protease.
"Presence of a von Willebrand factor (vWf) Fragment in Type IIa von Willebrand's disease (vWd)", Clinical Research, vol. 32, pp. 316A, 1984.
"Inhibition of von Willebrand Factor Fragmentation in Stored Plasma Containing Platelets by Inhibitors of the Calcium-Activated Protease", American Heart Association. (presented at 57th Meeting of American Heart Association, Nov., 1984).
"Understanding von Willebrand's Desease", The National Hemophilia Foundation 1978, background pamphlet describing von Willebrand's disease.
Kunicki Thomas J.
Montgomery Robert R.
Russel Jeffrey E.
The Blood Center Research Foundation
LandOfFree
Method for maintaining intact, non-degraded factor VIII/von-Will does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for maintaining intact, non-degraded factor VIII/von-Will, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for maintaining intact, non-degraded factor VIII/von-Will will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1069125